How Do Analysts Perceive Inhibikase Therapeutics Inc (IKT)?

Inhibikase Therapeutics Inc (IKT) saw downtrend of -0.42% in the recent trading with $2.36 being its most recent. The current price level -57.91% lower than the highest price of $5.61 marked by the stock while trading over the past 52-weeks, whereas it is 198.73% higher than the lowest price of $0.79 the company dropped to […]